Daunorubicin Hydrochloride
Cat.No:ID2260 Solarbio
CAS:23541-50-6
Molecular Formula:C27H29NO10·HCl
Molecular Weight:563.98
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Red Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Anti-Infection > Antibiotic > Daunorubicin HydrochlorideCAS:23541-50-6
Molecular Formula:C27H29NO10·HCl
Molecular Weight:563.98
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Red Solid
Qty:
Size:
| CAS | 23541-50-6 |
| Name | Daunorubicin Hydrochloride |
| Molecular Formula | C27H29NO10·HCl |
| Molecular Weight | 563.98 |
| Solubility | Soluble in Water/DMSO ≥10mg/mL |
| Purity | HPLC≥98% |
| Appearance | Red Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 245-723-4 |
| MDL | MFCD04974507 |
| SMILES | O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O.[H]Cl |
| InChIKey | GUGHGUXZJWAIAS-QQYBVWGSSA-N |
| InChI | InChI=1S/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1 |
| PubChem CID | 62770 |
| Target Point | Antibiotic;Topoisomerase |
| Passage | Anti-infection;DNA Damage/DNA Repair |
| Background | Daunorubicin Hydrochloride is an anthracycline antibiotic and a topoisomerase II (Topo II) inhibitor that inhibits DNA and RNA synthesis. Daunorubicin Hydrochloride has potent antitumor activity, inhibiting cancer cell viability and inducing apoptosis and necrosis. |
| Biological Activity | Daunorubicin hydrochloride是具有有效抗肿瘤活性的DNA拓扑异构酶II抑制剂[1-4]。 |
| Data Literature Source | [1]. Lehmann M,et al. Activity of topoisomerase inhibitors daunorubicin,idarubicin,and aclarubicin in the Drosophila Somatic Mutation and Recombination Test. Environ Mol Mutagen. 2004;43(4):250-7. [2]. Svensson SP,et al. Melanin inhibits cytotoxic effects of Doxorubicin and Daunorubicin in MOLT 4 cells. Pigment Cell Res. 2003 Aug;16(4):351-4 [3]. Gervasoni JE Jr,et al. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and Daunorubicin by induction of both necrosis and apoptosis. Anticancer Res. 2004 Sep-Oct;24(5A):2617-26 [4]. Arozal W,et al. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. Toxicology. 2011 Jan 11;279(1-3):91-9 |
| Unit | Bottle |
| Specification | 5mg 10mM*1mL in DMSO 10mM*1mL in Water 10mg 20mg 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download